# Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS)

> **NCT03781258** · NA · UNKNOWN · sponsor: **Institute for Clinical and Experimental Medicine** · enrollment: 20 (estimated)

## Conditions studied

- Heart Failure
- Cardiovascular Diseases

## Interventions

- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT03781258
- **Lead sponsor:** Institute for Clinical and Experimental Medicine
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-23
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03781258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03781258, "Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03781258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*